Using noninvasive imaging (Magnetic Resonance Imaging (MRI) ) for the first time in diabetes research, physicians at Massachusetts General Hospital and Harvard Medical School have discovered how it may aid in the early diagnosis, staging, and treatment of diabetes.
"With noninvasive MRI we have the ability to evaluate beta cell mass, a major factor of insulin secretion that is significantly reduced in type two diabetes and almost gone in type one,” said Anna Moore, MD, lead author of the study. “Knowing the number of functional beta cells left would allow physicians to develop the most appropriate treatment plans for their patients. It would also allow them to respond, change or manipulate those treatment plans at any time,” she said.
- Diabetes Pharmacist has been named one of the 100 Best Blogs for Pharmacy Students by Jill Gordon on Nursing Schools.Net., a nursing school network and directory.
No comments:
Post a Comment